1-206507804-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182663.4(RASSF5):c.202G>T(p.Gly68Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000332 in 1,398,482 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 1 hom. )
Consequence
RASSF5
NM_182663.4 missense
NM_182663.4 missense
Scores
1
3
12
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
RASSF5 (HGNC:17609): (Ras association domain family member 5) This gene is a member of the Ras association domain family. It functions as a tumor suppressor, and is inactivated in a variety of cancers. The encoded protein localizes to centrosomes and microtubules, and associates with the GTP-activated forms of Ras, Rap1, and several other Ras-like small GTPases. The protein regulates lymphocyte adhesion and suppresses cell growth in response to activated Rap1 or Ras. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.004478842).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASSF5 | NM_182663.4 | c.202G>T | p.Gly68Trp | missense_variant | 1/6 | ENST00000579436.7 | NP_872604.1 | |
RASSF5 | NM_182664.4 | c.202G>T | p.Gly68Trp | missense_variant | 1/5 | NP_872605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASSF5 | ENST00000579436.7 | c.202G>T | p.Gly68Trp | missense_variant | 1/6 | 1 | NM_182663.4 | ENSP00000462099.1 | ||
RASSF5 | ENST00000581503.6 | c.202G>T | p.Gly68Trp | missense_variant | 1/4 | 1 | ENSP00000464039.2 | |||
RASSF5 | ENST00000580449.5 | c.202G>T | p.Gly68Trp | missense_variant | 1/5 | 1 | ENSP00000462544.1 |
Frequencies
GnomAD3 genomes AF: 0.00187 AC: 283AN: 151500Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
283
AN:
151500
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000115 AC: 3AN: 25996Hom.: 0 AF XY: 0.000124 AC XY: 2AN XY: 16176
GnomAD3 exomes
AF:
AC:
3
AN:
25996
Hom.:
AF XY:
AC XY:
2
AN XY:
16176
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000145 AC: 181AN: 1246878Hom.: 1 Cov.: 35 AF XY: 0.000142 AC XY: 87AN XY: 611126
GnomAD4 exome
AF:
AC:
181
AN:
1246878
Hom.:
Cov.:
35
AF XY:
AC XY:
87
AN XY:
611126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00187 AC: 283AN: 151604Hom.: 0 Cov.: 33 AF XY: 0.00190 AC XY: 141AN XY: 74100
GnomAD4 genome
AF:
AC:
283
AN:
151604
Hom.:
Cov.:
33
AF XY:
AC XY:
141
AN XY:
74100
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.202G>T (p.G68W) alteration is located in exon 1 (coding exon 1) of the RASSF5 gene. This alteration results from a G to T substitution at nucleotide position 202, causing the glycine (G) at amino acid position 68 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
PrimateAI
Pathogenic
D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MutPred
Loss of methylation at R67 (P = 0.0222);Loss of methylation at R67 (P = 0.0222);Loss of methylation at R67 (P = 0.0222);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at